Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis

被引:85
作者
Yawalkar, N
Schmid, S
Braathen, LR
Pichler, WJ
机构
[1] Harvard Inst Med, Harvard Skin Dis Res Ctr, Boston, MA 02115 USA
[2] Univ Bern, Inselspital, Clin Rheumatol & Clin Immunol Allergol, CH-3010 Bern, Switzerland
[3] Univ Bern, Inselspital, Dermatol Clin, CH-3010 Bern, Switzerland
关键词
atopic dermatitis; granzyme B; immunohistochemistry; perforin; psoriasis; T cells;
D O I
10.1046/j.1365-2133.2001.04222.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Infiltration of the skin by pathogenic T cells is regarded as a key factor in the development of inflammatory skin diseases such as atopic dermatitis (AD) and psoriasis. Objectives To investigate whether T cells containing cytotoxic proteins may contribute to the generation of skin inflammation in these skin diseases. Methods Skin biopsy specimens were obtained from non-lesional and lesional skin of patients with chronic AD (n = 8) and psoriasis (n = 6), and from non-atopic controls with normal skin (n = 6). Expression of perforin and granzyme B was investigated by immunohistochemistry. Results A significant enhancement of perforin and granzyme B expression was observed in lesional AD skin as compared with normal skin, non-lesional AD skin and psoriasis. Expression of these cytotoxic proteins was also increased in psoriasis as compared with normal skin and non-lesional psoriatic skin. Immunoreactivity for perforin and granzyme B was mainly found in the cytoplasm of lymphocytic cells located in the perivascular infiltrate. In AD increased numbers of positive cells were also observed focally at sites of spongiosis in the epidermis. Double immunostaining revealed that both CD4+ and CD8+ T cells are capable of expressing perforin and granzyme B. Conclusions Our data suggest that cytotoxic CD4+ and CD8+ T cells containing perforin and granzyme B may play an integral part in eliciting cutaneous inflammation in AD.
引用
收藏
页码:1133 / 1139
页数:7
相关论文
共 19 条
[1]  
[Anonymous], ACTA DERM VENERE S92, DOI [10.2340/00015555924447, DOI 10.2340/00015555924447]
[2]  
Behrendt C, 2000, EUR J DERMATOL, V10, P365
[3]   The clinical spectrum of atopic dermatitis [J].
Beltrani, VS .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (03) :S87-S98
[4]   PREDOMINANCE OF T LYMPHOCYTES IN THE DERMAL INFILTRATE OF ATOPIC-DERMATITIS [J].
BRAATHEN, LR ;
FORRE, O ;
NATVIG, JB ;
EGLARSEN, TE .
BRITISH JOURNAL OF DERMATOLOGY, 1979, 100 (05) :511-519
[5]   A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis [J].
Grewe, M ;
Bruijnzeel-Koomen, CAFM ;
Schöpf, E ;
Thepen, T ;
Langeveld-Wildschut, AG ;
Ruzicka, T ;
Krutmann, J .
IMMUNOLOGY TODAY, 1998, 19 (08) :359-361
[6]   In vivo expression of IL-12 and IL-13 in atopic dermatitis [J].
Hamid, Q ;
Naseer, T ;
Minshall, EW ;
Song, YL ;
Boguniewicz, M ;
Leung, DYM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (01) :225-231
[7]   CYTOTOXICITY MEDIATED BY T-CELLS AND NATURAL-KILLER-CELLS IS GREATLY IMPAIRED IN PERFORIN DEFICIENT MICE [J].
KAGI, D ;
LEDERMANN, B ;
BURKI, K ;
SEILER, P ;
ODERMATT, B ;
OLSEN, KJ ;
PODACK, ER ;
ZINKERNAGEL, RM ;
HENGARTNER, H .
NATURE, 1994, 369 (6475) :31-37
[8]   Clinical validation and guidelines for the SCORAD index: Consensus report of the European task force on atopic dermatitis [J].
Kunz, B ;
Oranje, AP ;
Labreze, L ;
Stalder, JF ;
Ring, J ;
Taieb, A .
DERMATOLOGY, 1997, 195 (01) :10-19
[9]   Atopic dermatitis: New insights and opportunities for therapeutic intervention [J].
Leung, DYM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (05) :860-876
[10]  
Ma XJ, 1997, CHEM IMMUNOL, V68, P1